Vyera Pharmaceuticals: Daraprim Legacy Ends in Liquidation
Vyera Pharmaceuticals, the company behind the infamous Daraprim price hike by Martin Shkreli, filed Subchapter V bankruptcy in Delaware in May 2023. The confirmed plan created a dual-track liquidating trust structure with creditor recoveries contingent on an orphan drug Priority Review Voucher.
Subchapter VHealthcare & life sciences